Genus annual stock-based compensation
2022
2023
2024
2025
2026
Genus Stock-Based Compensation Growth & History (GNS)
Genus's stock-based compensation was £10.4M for fiscal 2026.
View full Genus company overviewGenus annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | £10.4M | £3.5M | +50.72% |
| 2025 | 2025-06-30 | £6.9M | −£100,000 | −1.43% |
| 2024 | 2024-06-30 | £7.0M | £1.0M | +16.67% |
| 2023 | 2023-06-30 | £6.0M | £2.3M | +62.16% |
| 2022 | 2022-06-30 | £3.7M | — | — |
Genus stock-based compensation trends
Between the periods ended 2022-06-30 and 2026-06-30, Genus's stock-based compensation increased from £3.7M to £10.4M, a change of £6.7M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
reported stock-based compensation
TickerStat standardizes share-based compensation reported in company official filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genus source filings ↗Community posts
Genus announces a £60 million buyback after stronger annual earnings
Genus ($GNS-LSE) announced a £60 million share-buyback program after adjusted pre-tax profit rose 35% to £100.2 million. Revenue declined 2% to £658.1 million, but stronger profitability in its pig-genetics business and improvements in its ...
